Servier to acquire Edgewise muscular dystrophy business in $2.65 billion deal
The transaction includes an upfront payment of $1.55 billion, along with up to $1.1 billion in regulatory and commercial milestone payments
The transaction includes an upfront payment of $1.55 billion, along with up to $1.1 billion in regulatory and commercial milestone payments
Approved as a web-based pre-diagnostic tool for suspected rare diseases and classified as a Class A (non-sterile and non-measuring) medical device
The move marks one of the most significant coverage expansions yet in obesity care, bringing FDA-approved treatment options further into mainstream insurance plans rather than out-of-pocket reach
BMS is moving beyond conversational AI into what it describes as “agentic” systems
The formulation contains 0.075% Capsaicin, a clinically proven ingredient along with menthol, camphor and eucalyptus oil
Early implementation of West Synchrony S1 platform aims to accelerate biologics and vaccine development while reducing manufacturing risk for biopharma partners
The 4,000-square-foot facility is designed as a hands-on hub where customers can work directly with scientists and engineers
The summit will bring together 1,200+ delegates, 100+ international faculty from 25 countries
EUDRAGIT polymers remain a cornerstone technology in oral drug delivery
The webinar series will showcase next-gen imaging technologies, global expert insights, and hands-on sessions on microscopy innovations
Subscribe To Our Newsletter & Stay Updated